LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 16.85 | 17.25 | 1 | 655 | 0.0015 | -0.4188 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 16.85 | 17.25 | 1037 | 655 | 1.5818 | 1.1826 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 18.82 | 17.25 | 1 | 800 | 0.0012 | -0.4022 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 18.82 | 17.25 | 1108 | 800 | 1.3841 | 1.1210 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 18.82 | 17.25 | 1 | 800 | 0.0012 | -0.4022 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 18.82 | 17.25 | 1163 | 800 | 1.4528 | 1.1396 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 20.79 | 17.25 | 3 | 1001 | 0.0030 | -0.2581 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 20.79 | 17.25 | 1204 | 1001 | 1.2020 | 1.0638 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 20.79 | 17.25 | 1 | 1001 | 0.0010 | -0.3849 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 20.79 | 17.25 | 1287 | 1001 | 1.2849 | 1.0874 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 22.76 | 17.25 | 1 | 1193 | 0.0008 | -0.3725 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 22.76 | 17.25 | 1285 | 1193 | 1.0766 | 1.0243 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 22.76 | 17.25 | 3 | 1193 | 0.0025 | -0.2489 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 22.76 | 17.25 | 1385 | 1193 | 1.1604 | 1.0493 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 24.73 | 17.25 | 3 | 1290 | 0.0023 | -0.2450 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 24.73 | 17.25 | 1397 | 1290 | 1.0828 | 1.0257 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 24.73 | 17.25 | 2 | 1290 | 0.0016 | -0.2926 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 24.73 | 17.25 | 1473 | 1290 | 1.1417 | 1.0430 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 26.70 | 17.25 | 2 | 1466 | 0.0014 | -0.2855 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 26.70 | 17.25 | 1528 | 1466 | 1.0418 | 1.0128 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 26.70 | 17.25 | 2 | 1466 | 0.0014 | -0.2855 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 26.70 | 17.25 | 1571 | 1466 | 1.0711 | 1.0215 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 28.67 | 17.25 | 3 | 1653 | 0.0018 | -0.2334 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 28.67 | 17.25 | 1657 | 1653 | 1.0023 | 1.0007 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 28.67 | 17.25 | 1 | 1653 | 0.0006 | -0.3512 | MN20160310_N02 | D18 |